dacarbazine has been researched along with Neuroectodermal Tumors, Primitive, Peripheral in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 2 (66.67) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (33.33) | 2.80 |
Authors | Studies |
---|---|
Meyers, PA; Slotkin, EK | 1 |
Deitmer, T; Eising, E; Naszaly, A; Pötter, R | 1 |
Lazerson, J; Munn, RJ; Turner, EA; Woerner, SJ | 1 |
2 review(s) available for dacarbazine and Neuroectodermal Tumors, Primitive, Peripheral
Article | Year |
---|---|
Irinotecan dose schedule for the treatment of Ewing sarcoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Dacarbazine; Humans; Irinotecan; Neoplasm Recurrence, Local; Neuroectodermal Tumors, Primitive, Peripheral; Sarcoma, Ewing; Temozolomide | 2023 |
Olfactory neuroblastoma (esthesioneuroblastoma) in a 2-year-old boy.
Topics: Antineoplastic Combined Chemotherapy Protocols; Blindness; Child, Preschool; Combined Modality Therapy; Cranial Irradiation; Cyclophosphamide; Dacarbazine; Doxorubicin; Epistaxis; Humans; Male; Maxillary Sinus Neoplasms; Neuroectodermal Tumors, Primitive, Peripheral; Prognosis; Skull Neoplasms; Vincristine | 1986 |
1 other study(ies) available for dacarbazine and Neuroectodermal Tumors, Primitive, Peripheral
Article | Year |
---|---|
[Role of radiotherapy in esthesioneuroblastoma].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Cranial Nerve Neoplasms; Cyclophosphamide; Dacarbazine; Doxorubicin; Humans; Male; Neoplasm Recurrence, Local; Neuroectodermal Tumors, Primitive, Peripheral; Olfactory Nerve; Paranasal Sinus Neoplasms; Radiotherapy, High-Energy; Vincristine | 1988 |